Pacira BioSciences' Research & Development rose 35.92% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.4 million, marking a year-over-year increase of 34.04%. This contributed to the annual value of $81.6 million for FY2024, which is 6.98% up from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Research & Development is $26.0 million, which was down 7.92% from $28.2 million recorded in Q2 2025.
Pacira BioSciences' Research & Development's 5-year high stood at $28.2 million during Q2 2025, with a 5-year trough of $11.6 million in Q3 2021.
Over the past 3 years, Pacira BioSciences' median Research & Development value was $20.3 million (recorded in 2024), while the average stood at $21.6 million.
As far as peak fluctuations go, Pacira BioSciences' Research & Development surged by 109.04% in 2022, and later fell by 28.38% in 2023.
Pacira BioSciences' Research & Development (Quarterly) stood at $15.5 million in 2021, then increased by 12.83% to $17.5 million in 2022, then increased by 11.19% to $19.5 million in 2023, then increased by 22.78% to $23.9 million in 2024, then spiked by 35.92% to $26.0 million in 2025.
Its last three reported values are $26.0 million in Q3 2025, $28.2 million for Q2 2025, and $25.3 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value